http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107652239-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7bae7cf399c53b51787e575edaf8b820 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-90 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P23-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20 |
| filingDate | 2017-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_015a09c268791f0abb2cc2c9a4cef4c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa3bf7edf912431b0cdf508aa90aa84f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78bb7774e318858d136201b18d68e2c8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df05e5d2980c498fe390a7909fa06e81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d8b1b619ebfbba55da53b1daaf81211 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2d64f0da0ad2ea1baee6efff520e9bc |
| publicationDate | 2018-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107652239-A |
| titleOfInvention | N-substituted imidazole carboxylate compound, preparation method and use |
| abstract | N-substituted imidazole carboxylate compound with formula (I), preparation method and application. In the formula, C* is an R-type chiral carbon atom, R 1 and R 2 are independently selected from H, methyl, ethyl, cyclopropyl, cyclobutyl or isopropyl, or C 2 is formed by R 1 and R 2 ~5 propene group; R 3 is a substituted or unsubstituted C 1~18 saturated or unsaturated aliphatic hydrocarbon or aromatic hydrocarbon, wherein the aliphatic hydrocarbon includes straight chain, branched chain or cyclic aliphatic hydrocarbon group. Such compounds or pharmaceutically acceptable salts thereof can be used to prepare centrally depressive drugs that produce sedative, hypnotic and/or anesthetic effects on humans or animals, can produce rapidly reversible anesthetic effects, and can be rapidly metabolized into inactive etomidate Esteric acid, the quality of recovery after drug withdrawal is good; the corticosteroid function of the body can be quickly restored after a single administration or continuous administration, the incidence of muscle tremors after medication is low, and the recovery is rapid after drug withdrawal. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112174890-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112142746-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11208385-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018153228-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112142746-A |
| priorityDate | 2017-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.